豪美新材(002988.SZ):與埃珂森簽訂鋁錠採購合同 預估採購金額約18億元
格隆匯 1 月 26日丨豪美新材(002988.SZ)公佈,隨着募投項目將在2021年陸續投產,鋁型材生產能力逐步擴大,為充分保障原材料的供應,公司與埃珂森(上海)企業管理有限公司(“埃珂森”)就公司2021年度鋁錠採購簽訂合同。
合同約定公司2021年度向埃珂森採購鋁錠12萬噸,履行期限自2021年1月16日至2022年1月15日,按當前SHEF交貨當月合約價格測算,預估採購金額約18億元(含税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.